4- (N- (iodoacetoxy)ethyl- N- methyl)amino- 7- nitrobenz- 2- oxa- 1,3- diazole

fluorescent probe

Also Known As:

4-(N-(iodoacetoxy)ethyl)methylamino-7-nitro-2,1,3-benzoxadiazole; IANBD; iodoacetamido-NBD; Acetic acid, iodo-, 2-(methyl(7-nitro-4-benzofurazanyl)amino)ethyl ester

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Oxazoles: 89
      - Oxadiazoles: 146
        4-(N-(iodoacetoxy)ethyl-N-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole: 2

Experts

1.	Choi, Boem Kyu: 1 article (12/2020)
2.	Choi, Yongdoo: 1 article (12/2020)
3.	Jang, Hyonchol: 1 article (12/2020)
4.	Kim, Hee Yeon: 1 article (12/2020)
5.	Kim, Hyunjin: 1 article (12/2020)
6.	Lee, Eun Young: 1 article (12/2020)

Related Diseases

1.	Acute Kidney Injury (Acute Renal Failure) 12/01/2020 - "In particular, Q-annexin V shows superior utility for in vivo apoptosis fluorescence imaging in animal models of cisplatin-induced acute kidney injury and cancer immune therapy, compared to the conventional polarity-sensitive pSIVA-IANBD or annexin V-Alexa647 conjugates."
2.	Neoplasms (Cancer) 12/01/2020 - "In particular, Q-annexin V shows superior utility for in vivo apoptosis fluorescence imaging in animal models of cisplatin-induced acute kidney injury and cancer immune therapy, compared to the conventional polarity-sensitive pSIVA-IANBD or annexin V-Alexa647 conjugates."
3.	Diabetes Mellitus 02/01/1987 - "The effects of aging and diabetes mellitus were studied by fluorescence measurements, including emission maximum, quantum yield and polarization, using both intrinsic probes (tryptophan and non-tryptophan) and extrinsic probes [4-(N-iodoacetoxy)N-methylamino-7-nitrobenz-2-oxa-1,3-diazole (IANBD) and 6-(p-toluidinyl)naphthalene-2-sulfonate (TNS)]. "

Related Drugs and Biologics

1.	Annexin A5
2.	Annexins
3.	Tryptophan (L-Tryptophan)
4.	Cisplatin (Platino)
5.	2-(4-toluidino)-6-naphthalenesulfonic acid (TNS)

Related Therapies and Procedures

1.	Therapeutics